Lipidomics-Based Methods for Cancer Care Engineering
Posted 14 Oct, 2008 in Series
| Abstract | Lidipomics is a relatively new field and the inclusion of this analysis in Cancer Care Engineering OMIC analyses represents a novel addition and provides great promise for increasing the value of the predictive statistical models that will be generated. While genomic, epigenomic, and proteomic approaches are being applied to the development of convenient and reliable biomarkers for CRC, a blood test with desired specificity and sensitivity for the early detection and reliable monitoring of disease progression has not been developed. The Xu laboratory’s lipidomic approach will have an important and complimentary impact in this area. Xu’s studies have already shown that a group of lysophospholipids can detect CRC with high sensitivity and specificity. Confirmation and expansion of these studies will be pivotally important for the critical evaluation of the clinical usage of these biomarkers. |
|---|---|
| Cite this work | If you reference this work in a publication, please cite as follows: |
| Tags |